American Society of Hirudotherapy

Hirudin P6

Tyrosine-sulfated, O-glycosylated hirudin variant from Hirudo medicinalis — Maxwell 2023 chemical-synthesis study reveals sulfation increases thrombin inhibition ~10-fold.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 27, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Hirudin P67 kDa
Molecular weight (kilodaltons) of Hirudin P6 (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
In vitro
Drug vs leech
Synthetic analog
Safety domains
Bleeding

Clinical translation limit

Hirudin P6's enhanced in vitro thrombin inhibition does NOT establish clinical efficacy of whole-leech therapy. No FDA-approved hirudin P6 derivative exists; clinical hirudin analogs (lepirudin, desirudin, bivalirudin) lack the P6 post-translational modification pattern.

Molecular Profile

Category
Anticoagulant
Evidence tier
Preclinical
Molecular weight
7,000 Da
Source species
Hirudo medicinalis
Discovered
2023 · Maxwell JWC et al.

Biological Targets

  • → thrombin (Factor IIa); enhanced binding via tyrosine sulfation and O-glycosylation

Key Citations

  1. Maxwell JWC et al. (2023), Acc Chem Res · PMID 37708351

External Resources

    Related Anticoagulant Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.